Analyst Ratings for Medivation Inc (MDVN)

Updated: 2016-09-27



Several price targets were given for MDVN by the analysts covering the stock. The most optimistic price target was 82, implying a possible profit of 0.69 percent. The most pessimistic analyst gave a price target of 64, implying potential capital losses of -21.41 percent. Note that investment analysts can be biased in their reporting on companies's ratings and price targets.

In the last 30 days, analysts have changed their quarterly earnings estimates downwards by an average of -1.32 percent. The average change in earnings estimates over the last 90 days is 1.37 percent. Meanwhile, fiscal year estimates have been revised upwards by 0 percent, compared to last month. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes 8.29 percent.

Investors like to see analysts making revisions in the same direction, as that raises confidence in the revisions. 0 analysts have revised their quarterly estimates upwards in the past 30 days, while 1 analysts revised their estimates downwards. Over the same time period, 0 analysts revised their FY earnings estimates upwards, while 1 analysts made negative revisions to their fiscal year's estimates.

In the trailing 52-weeks, MDVN hit 81.48 at the highest peak, while it's lowest trading point was 26.41. Currently the stock is 208.37 percent higher than its low, and 0.05 percent lower than its 52-week high. MDVN has a price/earnings ratio of 0. Investors typically compare the P/E ratio to a company's peers in the industry. The MDVN value stock report compares MDVN to some of its peers using value stock charts. The market cap of MDVN is $13.57 billion. MDVN's next earnings release will be on 2016-11-03, which is -806 days away.